EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma

Xing Huang, Feng Zhao, Quan Wu, Zitong Wang iD, Haiyue Ren, Qiqi Zhang, Zhe Wang, Jin Xu

Cancers · 27.02.2023 · 15 (5) · 1502

DOI: 10.3390/cancers15051502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 27.02.2023. Verfasst von Xing Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Technology Research from the Department of Education of Liaoning Province, the 345 Talent Project of Shengjing Hospital of China Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with a poor prognosis. For PDAC, an increase in the survival time of patients and a reduction mortality have not yet successfully been achieved. In many research works, Kinesin family member 2C (KIF2C) is highly expressed in several tumors. Nevertheless, the role of KIF2C in pancreatic cancer is unknown. In this study, we found that KIF2C expression is significantly upregulated in human PDAC tissues and cell lines such as ASPC-1 and MIA-PaCa2. Moreover, KIF2C upregulation is associated with a poor prognosis when combining the expression of KIF2C with clinical information. Through cell functional assays and the construction of animal models, we showed that KIF2C promotes PDAC cell proliferation, migration, invasion, and metastasis, both in vitro and in vivo. Finally, the results of sequencing showed that the overexpression of KIF2C causes a decrease in some proinflammatory factors and chemokines. The cell cycle detection indicated that the pancreatic cancer cells in the overexpressed group had abnormal proliferation in the G2 and S phases. These results revealed the potential of KIF2C as a therapeutic target for the treatment of PDAC.

Schlagwörter

Stichwörter der Autor:innen

KIF2CPDACcell cycleinvasionmigrationprognosisproliferation

Autor:innen und Institutionen

  • Department of General Surgery, Shengjing Hospital, China Medical University, Shenyang 110004, China.
  • Department of Stem Cells and Regenerative Medicine, China Medical University, Shenyang 110122, China.
  • Department of Pathology, Shengjing Hospital, China Medical University, Shenyang 110004, China.

ORCID-Profile: Zitong Wang

Förderung

  • National Natural Science Foundation of China
  • the Technology Research from the Department of Education of Liaoning Province
  • the 345 Talent Project of Shengjing Hospital of China Medical University

Zitieren

APA

Huang, X., Zhao, F., Wu, Q., Wang, Z., Ren, H., Zhang, Q., Wang, Z., & Xu, J. (2023). KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma. Cancers, 15(5), 1502. https://doi.org/10.3390/cancers15051502

Vancouver

Huang X, Zhao F, Wu Q, Wang Z, Ren H, Zhang Q, et al. KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma. Cancers. 2023;15(5):1502. doi:10.3390/cancers15051502

BibTeX
@article{Huang2023,
  author = {Huang, Xing and Zhao, Feng and Wu, Quan and Wang, Zitong and Ren, Haiyue and Zhang, Qiqi and Wang, Zhe and Xu, Jin},
  title = {KIF2C Facilitates Tumor Growth and Metastasis in Pancreatic Ductal Adenocarcinoma},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1502},
  doi = {10.3390/cancers15051502}
}
Kostenlos starten →